| Drug Name: | samarium (153sm) lexidronam (154427-83-5) |
|---|---|
| PubChem ID: | 53463038 |
| SMILES: | C(CN(CP(=O)([O-])[O-])CP(=O)([O-])[O-])N(CP(=O)([O-])[O-])CP(=O)([O-])[O-].[Sm+3] |
| InchiKey: | JSTADIGKFYFAIY-UHFFFAOYSA-F |
| Therapeutic Category: |
| Molecular Weight (dalton) | : | 578.42 |
| LogP | : | -6.9248 |
| Ring Count | : | 0 |
| Hydrogen Bond Acceptor Count | : | 14 |
| Hydrogen Bond Donor Count | : | 0 |
| Total Polar Surface Area | : | 259.24 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category
| Toxicity | Source |
|---|---|
| Haematotoxicity | PROTECT |
| Nerve Root Compression | PROTECT |